Brain health pro

2 papers6 findings

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

Labs are independent when their papers share no last author and no institution.

Against: findings that point the other way from most findings on the same outcome.

On aging: the drug’s trials ARN judged to be about aging, of every trial that tests it for any use.

No results posted: trials that ended more than a year ago with no results on ClinicalTrials.gov and no paper in ARN’s record.

Company ties: findings with an author at a company, or from a paper whose competing-interests statement declares ties to one.

2 independent labs in 2 countries

Human trial2

Outcomes

Modifiable risk factors for alzheimer's disease

upin humans1

1 study

Brain health pro improves modifiable risk factors for alzheimer's disease in humans.
“BHPro, a relatively inexpensive web‐based multidomain intervention, improves key modifiable risk factors for Alzheimer's disease following a program duration of either 6 or 12 months.”
Human trial12 monthsn = 353
A web‐based multidomain intervention improves modifiable risk factors for Alzheimer's disease
AAIC 2025 abstract23 Dec 2025

Physical activity

upin humans1

1 study

Brain health pro improves physical activity in humans.
“physical activity, nutrition, cognitive engagement, and sleep showed statistically significant improvements at both 6 and 12 months.”
Human trial12 monthsn = 353
A web‐based multidomain intervention improves modifiable risk factors for Alzheimer's disease
AAIC 2025 abstract23 Dec 2025

Composite lifestyle risk score

upin humans1

1 study

Brain health pro improves composite lifestyle risk score in humans (standardized change = 0.162, p < 0.001).
“revealed a significant positive change in a composite lifestyle risk score at 6 months (standardized change = 0.162; p < 0.001)”
Human trial6 monthsn = 353
A web‐based multidomain intervention improves modifiable risk factors for Alzheimer's disease
AAIC 2025 abstract23 Dec 2025